MedTech News
.................... by Andrew Celentano

Engineers find a way to deliver drugs directly to the esophagus
There are few treatment options available for people with disorders of the esophagus. Delivering drugs directly to this part of the body is difficult, so patients are usually treated with systemic drugs, which can have unwanted side effects.

Brain-like organoids reveal how Ebola persists and spreads for 120 days
Following infection, the Ebola virus can survive unnoticed in the human body for months or even years, hiding in areas with little immune surveillance like the central nervous system.

Researchers develop injectable device to control nerves without surgery
Researchers from NYU Abu Dhabi, in collaboration with Cleveland Clinic Abu Dhabi, have developed a tiny, injectable medical device that introduces a new approach to treating chronic pain and movement disorders by controlling nerve activity without the need for surgery, batteries or wires, offering a simpler and less invasive way to treat neurological conditions.

Wave Neuroscience wins FDA clearance for precision PTSD therapy
Wave’s MeRT platform records individual patient brain data to tailor transcranial magnetic stimulation (TMS) therapy for PTSD treatment.

OraSure Gains FDA Clearance for At-Home STI Sample Collection Kit
The clearance supports decentralized urine sample collection for molecular STI testing using Roche’s cobas platforms.

Programmable wound zipper adapts to complex skin injuries, improving healing in rats
To utilize flexible bioelectronic systems for wound healing, researchers designed the MSWZ. The MSWZ is made up of a mechanical metamaterial in a lattice structure that shrinks and responds like human skin, a reliable conductive layer, and a breathable, flexible encapsulation material.

Natural protein scaffold may speed bone healing by growing blood vessels at same time
For patients suffering from traumatic injuries that leave behind “volumetric” gaps—where significant bone and blood vessels are lost—the clock is always ticking. Without a nearby blood supply, cells in the center of a large injury cannot survive, often leading to permanent tissue loss or failed grafts.

Popular joint pain supplement might increase Alzheimer’s risk, study says
Glucosamine use is associated with a 25% higher odds that a person will progress from mild cognitive impairment to dementia and Alzheimer’s disease, researchers report in the journal Nature Metabolism.